山东达因海洋生物制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
43
NMPA:43
Drug Approvals
Sodium Valproate Oral Solution
- Product Name
- 丙戊酸钠口服溶液
- Approval Number
- 国药准字H20254187
- Approval Date
- May 13, 2025
NMPA
Desloratadine Oral Solution
- Product Name
- 地氯雷他定口服溶液
- Approval Number
- 国药准字H20247314
- Approval Date
- Dec 11, 2024
NMPA
Oral Rehydration Salts Powder(Ⅲ)
- Product Name
- 口服补液盐散(Ⅲ)
- Approval Number
- 国药准字H20193219
- Approval Date
- Mar 21, 2024
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 盐酸托莫西汀胶囊
- Approval Number
- 国药准字H20234590
- Approval Date
- Dec 5, 2023
NMPA
Rosiglitazone Tartrate Tablets
- Product Name
- 酒石酸罗格列酮片
- Approval Number
- 国药准字H20080406
- Approval Date
- Apr 20, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found